This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Instytut Immunologii I Terapii Doswiadczalnej Pan. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Dmitry Nevozhay: Innovator in Drug-Carrier Conjugates
Introduction
Dmitry Nevozhay is a notable inventor based in Houston, TX (US). He has made significant contributions to the field of drug delivery systems, particularly through his innovative methods in producing polyanionic drug-carrier conjugates. His work focuses on enhancing the therapeutic properties of macromolecules, which can lead to improved medical treatments.
Latest Patents
Dmitry holds a patent for a method of production of polyanionic drug-carrier conjugates. This invention involves a unique process where a polyanionic macromolecule, primarily a protein composed of polar amino acids such as lysine, arginine, aspartic acid, and glutamic acid, undergoes a reaction between amine groups and the cyclic anhydride of dicarboxylic acid. This reaction results in a shift towards a more negatively charged carrier, which enhances the therapeutic properties of the modified macromolecules. He has 1 patent to his name.
Career Highlights
Dmitry Nevozhay is associated with the Institute of Immunology and Experimental Therapy, where he continues to advance his research in drug delivery systems. His innovative approach has the potential to revolutionize how drugs are delivered in medical treatments, making them more effective and targeted.
Collaborations
Dmitry collaborates with esteemed colleagues such as Joanna Wietrzyk and Janusz Boratyński. Their combined expertise contributes to the advancement of research in the field of immunology and drug delivery.
Conclusion
Dmitry Nevozhay is a pioneering inventor whose work in polyanionic drug-carrier conjugates is paving the way for advancements in therapeutic applications. His contributions are significant in the realm of drug delivery, showcasing the importance of innovation in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile